Insight Molecular Diagnostics (IMDX) Gross Profit Growth (1y) (2021 - 2026)
Insight Molecular Diagnostics (IMDX) Gross Profit Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 9.56% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 2.50% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 12.14% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 14.32% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 8.47% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 119.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 10.79% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 12.13% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 8.91% |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | -98.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -98.87% |
| Dec 31, 2025 | -16.64% |
| Sep 30, 2025 | 178.00% |
| Jun 30, 2025 | 600.00% |
| Mar 31, 2025 | 2,844.44% |
| Dec 31, 2024 | 608.55% |
| Sep 30, 2024 | -79.84% |
| Jun 30, 2024 | -81.62% |
| Mar 31, 2024 | 350.00% |
| Dec 31, 2023 | -333.33% |
| Sep 30, 2023 | 192.19% |
| Jun 30, 2023 | 777.42% |
| Mar 31, 2023 | -95.95% |
| Dec 31, 2022 | -101.04% |
| Sep 30, 2022 | 68.94% |
| Jun 30, 2022 | 107.87% |
| Mar 31, 2022 | 212.66% |
| Dec 31, 2021 | 1,321.13% |
| Sep 30, 2021 | -1,782.61% |
| Jun 30, 2021 | -77.48% |